Marinus Pharma (MRNS): O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti
Marinus Pharmaceuticals (MRNS) o'zining asosiy dori vositasining sotuvlarini xorijiy distribyutorlar orqali kengaytirmoqda va GURU.Markets ushbu grafikdagi ma'lumotlarni keltirmoqda, bunda PEG koeffitsiyenti trayektoriyasi o'sishni tasdiqlaydi. Biznes muvaffaqiyati klinikalarda ganaxolone joriy etilishiga asoslangan, rahbariyatning aktivlarni tijoratlashtirishdagi tajribasi esa kompaniyaning mavqeini mustahkamlaydi. Shu bilan birga, 0.00 yangi darajani qayd etmoqda, bu esa foydaga nisbatan qiymat dinamikasidan dalolat beradi.
Marinus Pharmaceuticals (MRNS) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- balans kapitallashuvi ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Marinus Pharmaceuticals|MRNS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti marinuspharma.com|MRNS - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Marinus|MRNS - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Marinus Pharmaceuticals|Oraliq qoplash koeffitsiyenti marinuspharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
MRNS - Sof foyda|Prognoz qilingan kelajakdagi foyda Marinus Pharmaceuticals|MRNS - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Marinus Pharma|MRNS - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Marinus|MRNS - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Marinus Pharmaceuticals|MRNS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi marinuspharma.com|MRNS - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Marinus Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:Marinus Pharmaceuticals Inc, MRNS
PEG koeffitsiyenti aktivning bozor qiymatining uning foyda o'sish sur'atiga nisbatan adolatli ekanligini o'lchaydi, bunda birdan past qiymat fundamental past baholanganlikni va o'sish potentsialini anglatadi. Baholash va foyda dinamikasi o'rtasidagi bog'liqlikni tahlil qilish orqali Marinus Pharmaceuticals (MRNS) investori epilepsiyaning kam uchraydigan shakllarini davolash uchun mo'ljallangan patentlangan dori vositalarining yuqori marjalari va shifoxona segmentining potentsialini hisobga olgan holda, pozitsiyaning xavfsizlik zaxirasini aniqlashi mumkin.
Marinus Pharmaceuticals raqobatchilari
PEG multiplikatori Biogen Inc (BIIB)|Narxning foydaga va o‘sish sur’atiga nisbati Neurocrine Biosciences Inc NBIX|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RGC|Axsome Therapeutics - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati acadia-pharm.com ACAD|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti VKTX|Narx-foyda va o‘sish multiplikatori SUPN|PEG multiplikatori Catalyst Corp|Narxning foydaga va o‘sish sur’atiga nisbati Denali Therapeutics (DNLI)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati harmonybiosciences.com|Biohaven - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AMLX|TRVI - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PRAX|AVXL: PEG multiplikatori|ceribell.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PRTA (Prothena Corporation plc) - PEG multiplikatori|PEG multiplikatori Alector Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|OMER (omeros.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Neurogene Inc. NGNE|ACIU - Narx-foyda va o‘sish multiplikatori|Voyager Therapeutics, Inc. - PEG multiplikatori|NMRA - PEG multiplikatori|SCLX: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Tevogen Bio Inc.|ACOG (Alpha Cognition Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda cogrx.com CGTX|Narx-foyda va o‘sish multiplikatori IKT (Inhibikase Therapeutics, Inc.)|PEG multiplikatori Cassava Sciences Inc (SAVA)|Assertio - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati COYA (Coya Therapeutics Inc)|VistaGen Therapeutics Inc - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ovid Therapeutics Inc. OVID|ABOS: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori CervoMed, Inc.|ATHE (Alterity Therapeutics Ltd.) - PEG multiplikatori|PEG multiplikatori Clene Nanomedicine|Narxning foydaga va o‘sish sur’atiga nisbati PepGen Inc. (PEPG)|Narxning foydaga va o‘sish sur’atiga nisbati JUNS (jupiterneurosciences.com)|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Annovis Bio Inc (ANVS)|GRCE - Narxning foydaga va o‘sish sur’atiga nisbati|Firefly Neuro (AIFF) - Narx-foyda va o‘sish multiplikatori|anewmeds.com (KLTO) - Narxning foydaga va o‘sish sur’atiga nisbati|NeuroSense Therapeutics Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Reviva Pharmaceuticals Holdings, Inc.|O‘sishni hisobga olgan narx-foyda koeffitsiyenti MTVA (MetaVia, Inc.)|Narxning foydaga va o‘sish sur’atiga nisbati NeurAxis, Inc (NRXS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati heliusmedical.com|Narxning foydaga va o‘sish sur’atiga nisbati Passage Bio PASG|NEUP: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Minerva Neurosciences, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Athira Pharma Inc|ADXN (Addex Therapeutics, Ltd.) - Narx-foyda va o‘sish multiplikatori|Alzamend Neuro (ALZN) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Cyclerion Therapeutics Inc.|PTIX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Pasithea Therapeutics (KTTA)|CRGT - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Avenue Therapeutics, Inc ATXI|BCLI - Narx-foyda va o‘sish multiplikatori|Cara Therapeutics, Inc. - PEG multiplikatori|CHRO - PEG multiplikatori|eliemtx.com (ELYM) - Narxning foydaga va o‘sish sur’atiga nisbati|Intra-Cellular Therapies, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|LBPH (Longboard Pharma) - PEG multiplikatori|NKGen Biotech Corp (NKGN) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|sagerx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Synaptogenix - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Trevena Inc. TRVN|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Anew Medical Inc. WENA|CERE (Cerevel Therapeutics) - Narx-foyda va o‘sish multiplikatori
